Correlation Between Virax Biolabs and Lexaria Bioscience
Can any of the company-specific risk be diversified away by investing in both Virax Biolabs and Lexaria Bioscience at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Virax Biolabs and Lexaria Bioscience into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Virax Biolabs Group and Lexaria Bioscience Corp, you can compare the effects of market volatilities on Virax Biolabs and Lexaria Bioscience and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Virax Biolabs with a short position of Lexaria Bioscience. Check out your portfolio center. Please also check ongoing floating volatility patterns of Virax Biolabs and Lexaria Bioscience.
Diversification Opportunities for Virax Biolabs and Lexaria Bioscience
0.39 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Virax and Lexaria is 0.39. Overlapping area represents the amount of risk that can be diversified away by holding Virax Biolabs Group and Lexaria Bioscience Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lexaria Bioscience Corp and Virax Biolabs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Virax Biolabs Group are associated (or correlated) with Lexaria Bioscience. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lexaria Bioscience Corp has no effect on the direction of Virax Biolabs i.e., Virax Biolabs and Lexaria Bioscience go up and down completely randomly.
Pair Corralation between Virax Biolabs and Lexaria Bioscience
Given the investment horizon of 90 days Virax Biolabs is expected to generate 1.72 times less return on investment than Lexaria Bioscience. In addition to that, Virax Biolabs is 1.84 times more volatile than Lexaria Bioscience Corp. It trades about 0.03 of its total potential returns per unit of risk. Lexaria Bioscience Corp is currently generating about 0.08 per unit of volatility. If you would invest 76.00 in Lexaria Bioscience Corp on September 12, 2024 and sell it today you would earn a total of 172.00 from holding Lexaria Bioscience Corp or generate 226.32% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Virax Biolabs Group vs. Lexaria Bioscience Corp
Performance |
| Timeline |
| Virax Biolabs Group |
| Lexaria Bioscience Corp |
Virax Biolabs and Lexaria Bioscience Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Virax Biolabs and Lexaria Bioscience
The main advantage of trading using opposite Virax Biolabs and Lexaria Bioscience positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Virax Biolabs position performs unexpectedly, Lexaria Bioscience can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lexaria Bioscience will offset losses from the drop in Lexaria Bioscience's long position.| Virax Biolabs vs. Revelation Biosciences | Virax Biolabs vs. Kiora Pharmaceuticals | Virax Biolabs vs. Quoin Pharmaceuticals Ltd | Virax Biolabs vs. Neurobo Pharmaceuticals |
| Lexaria Bioscience vs. Revelation Biosciences | Lexaria Bioscience vs. Zura Bio Limited | Lexaria Bioscience vs. Phio Pharmaceuticals Corp | Lexaria Bioscience vs. ZyVersa Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |